Skip to main content

Table 1 Comparison of clinical data of patients in different groups

From: Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization

Parameters

Group A

(n = 611)

Group B

(n = 85)

Group C

(n = 118)

Group D

(n = 307)

p value

Age (years)

32.69 ± 4.59

33.98 ± 4.89▲

36.81 ± 4.79▲

37.74 ± 5.16

< 0.001

Basal FSH (mIU/mL)

7.48 ± 2.20

8.81 ± 2.87▲

10.14 ± 4.57▲

11.24 ± 4.83

< 0.001

No. of AFCs (n)

12.29 ± 4.08

8.47 ± 1.72▲

4.53 ± 1.41▲

3.69 ± 1.59

< 0.001

AMH level (ng/ml)

3.46 ± 1.88

0.76 ± 0.24▲

1.94 ± 1.03▲

0.51 ± 0.30

< 0.001

Oocyte yield (n)

10.63 ± 5.14

5.13 ± 2.98▲

4.11 ± 2.50▲

2.10 ± 1.78

< 0.001

Poor ovarian response (%)

5.07%(31/611)

25.88%▲(22/85)

40.68%▲(48/118)

83.06%(255/307)

< 0.001

Fertilization rate (%)

72.41%(4702/6494)

73.85%(322/436)

73.20%(355/485)

73.37%(474/646)

0.862

Good-quality embryo rate (%)

41.01%(1961/4782)

45.51%▲

(152/334)

35.28%▲

(145/411)

25.21%(121/480)

0.004

Transplant cancellation rate (%)

33.88%(207/611)

32.94%(28/85)

46.61%(55/118)

68.73%(211/307)

< 0.001

Clinical pregnancy rate (%)

43.32%

(175/404)

43.86%▲(25/57)

23.81%▲(15/63)

25.00%(24/96)

< 0.001

  1. ▲Group B and Group C have significant differences. (P < 0.05)
  2. The main reasons for transplant cancellation in the four groups were different
  3. Group A: to prevent the occurrence of OHSS (55.56%, 115/207)
  4. Group B: no transplantable embryos (32.14%, 9/28) and to accumulate embryos (32.14%, 9/28)
  5. Group C: no transplantable embryos (29.09%, 16/55) and to accumulate embryos (23.64%, 13/55)
  6. Group D: no transplantable embryos (52.61%, 111/211) and to accumulate embryos (28.44%, 60/211)